DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading
DSN LINK STABLECARRIER WAVE LOCKORBITAL INDEX HOTSIGNAL CLOCK SYNCLOW NOISE FLOORFRAME BUFFER ONLINE
Loading portal core
25 articles
Oura Ring 5 is not just another smaller wearable, but an attempt to turn the smart ring into a quieter, always-on health monitoring layer.
BioVAT is not yet a practice-changing therapy, but it goes directly at heart failureâs hardest problem: lost myocardium that does not simply grow back.
A stem-cell-based heart patch has shown an early clinical signal in one of cardiologyâs hardest corners: advanced heart failure.
HELZ2 is not yet a new cholesterol drug, but it is a precise biological lead into how the liver decides how many atherogenic particles enter the blood.
A major international study raises the question of whether beta blockers should still be routinely prescribed after a mild heart attack in patients with preserved heart function.
Jorie Kraus was born with an ultra-rare disorder tied to a chromosome 10 gene deletion, and an AI tool used in a Mayo Clinic program helped clinicians find a treatment lead that changed her clinical course.
A new meta-analysis presented at the European Congress on Obesity in Istanbul puts a sharper number on a question already reshaping cardiometabolic medicine: how much drug-assisted weight loss lowers blood pressure.
Houston Methodist has used a personalized mRNA vaccine in a patient with osteosarcoma in an attempt to reduce relapse risk under FDA compassionate use.
New research suggests a daily GLP-1 pill could help maintain results achieved with semaglutide or tirzepatide.
Northwestern engineers and clinicians have built a wearable polygraph that tracks five body signals in real time to expose hidden stress, not deception.
A new mouse study suggests that restoring an animal's own youthful gut microbiome can slow biological liver aging and reduce early cancer-linked risk signals.
Automated evaluation can scale safety checks, but it must not pretend to be diagnosis.
Pragmata has finally climbed out of its delay capsule: IGN's review is not only a verdict on one Capcom game, but on the whole ritual of announcements that orbit players for years before landing.
Flinders Universityâs *SLEEP* study exposes a blind spot in sleep medicine: patients with erratic night-to-night apnea patterns face 30% higher cardiovascular risk than severity scores alone predict.
A 50-patient randomized trial found no reduction in heart attack size when using Impella CP pumps in high-risk STEMI patients without cardiogenic shock.
The allegations against Delve show why open-source attribution is a business risk, not just developer etiquette.
Pericardial fatâlong a suspected culprit in heart diseaseânow has an AI-powered measurement tool that outperforms traditional risk models by up to 20%.
A 16-week trial across 13 countries just gave pediatric cardiologists their first phase 3 data on mavacamten for obstructive HCM in youth.
A new study reveals AI depression detectors ace benchmarks by cheatingâmemorizing interviewer scripts instead of patient symptoms.
Current heart failure diagnostics rely on invasive catheters or radiationâyet a Oxford-led team just mapped cardiac oxygen use in three minutes using standard MRI machines.
IB101âs defined binding pocket marks a structural advance, but the compound has yet to enter preclinical testing.
A recent study published in Nature Medicine has found that a deep learning model using smartwatch data can predict peak oxygen uptake and unplanned healthcare events in patients with heart failure.
A Boston surgical team rehearsed a high-risk pediatric procedure on a digital twin of the patientâs heart before making the first incision.
The Hubble tension has haunted cosmology for yearsâa stubborn gap between two methods of measuring how fast our universe expands.
Obesity treatment may have just taken a measured step forward.
